| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
10,633 |
9,089 |
$1.18M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
4,826 |
4,234 |
$528K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,142 |
2,265 |
$257K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,852 |
1,647 |
$223K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,329 |
1,173 |
$121K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
860 |
780 |
$94K |
| 0240U |
|
953 |
800 |
$86K |
| 70450 |
Computed tomography, head or brain; without contrast material |
731 |
510 |
$83K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,513 |
2,425 |
$78K |
| 71046 |
Radiologic examination, chest; 2 views |
1,869 |
1,568 |
$54K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,470 |
1,130 |
$48K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
2,849 |
2,379 |
$42K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
248 |
222 |
$36K |
| 71045 |
Radiologic examination, chest; single view |
2,064 |
1,469 |
$32K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
140 |
109 |
$32K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,297 |
299 |
$31K |
| 80053 |
Comprehensive metabolic panel |
7,035 |
4,990 |
$30K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,008 |
2,400 |
$30K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,664 |
5,091 |
$26K |
| T1015 |
Clinic visit/encounter, all-inclusive |
257 |
208 |
$21K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,185 |
1,493 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,026 |
719 |
$15K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
990 |
947 |
$14K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
447 |
366 |
$14K |
| 84484 |
|
2,775 |
1,773 |
$12K |
| 87430 |
|
1,510 |
1,432 |
$12K |
| J3490 |
Unclassified drugs |
3,475 |
2,145 |
$11K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,124 |
1,056 |
$10K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
36 |
24 |
$9K |
| E0601 |
Continuous positive airway pressure (cpap) device |
713 |
557 |
$9K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
426 |
376 |
$9K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
587 |
333 |
$8K |
| G0378 |
Hospital observation service, per hour |
63 |
49 |
$8K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
354 |
232 |
$7K |
| 82553 |
|
1,240 |
843 |
$7K |
| 81025 |
|
1,603 |
1,455 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
10,216 |
6,619 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,742 |
1,325 |
$6K |
| 81001 |
|
3,876 |
3,037 |
$6K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,413 |
766 |
$4K |
| 84443 |
Thyroid stimulating hormone (TSH) |
402 |
340 |
$4K |
| 83880 |
|
333 |
231 |
$4K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
601 |
537 |
$4K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
427 |
280 |
$4K |
| 83690 |
|
1,188 |
893 |
$4K |
| 87070 |
|
639 |
597 |
$4K |
| 82550 |
|
1,450 |
974 |
$2K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
37 |
31 |
$2K |
| 85027 |
|
836 |
541 |
$2K |
| 94664 |
|
235 |
172 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,367 |
1,810 |
$2K |
| 87400 |
|
233 |
154 |
$2K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
16 |
14 |
$2K |
| 80061 |
Lipid panel |
269 |
224 |
$2K |
| 87631 |
|
33 |
32 |
$2K |
| 83735 |
|
869 |
549 |
$1K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
130 |
121 |
$1K |
| 87077 |
|
208 |
183 |
$1K |
| 85379 |
|
201 |
163 |
$1K |
| A7038 |
Filter, disposable, used with positive airway pressure device |
1,101 |
846 |
$971.75 |
| 82150 |
|
265 |
202 |
$703.14 |
| 85730 |
|
226 |
180 |
$698.11 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
34 |
29 |
$640.82 |
| A7037 |
Tubing used with positive airway pressure device |
141 |
118 |
$613.82 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
37 |
31 |
$573.27 |
| 87807 |
|
61 |
59 |
$551.44 |
| 97162 |
|
23 |
12 |
$544.90 |
| 87040 |
|
79 |
63 |
$480.59 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
321 |
191 |
$434.23 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,773 |
1,173 |
$375.21 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
195 |
130 |
$362.65 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
63 |
14 |
$323.47 |
| 73562 |
|
23 |
12 |
$322.54 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
60 |
48 |
$297.63 |
| 83605 |
|
36 |
28 |
$248.13 |
| 85610 |
|
216 |
109 |
$230.09 |
| 85007 |
|
263 |
144 |
$211.17 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
26 |
25 |
$184.54 |
| 87186 |
|
26 |
24 |
$178.41 |
| 80305 |
|
262 |
242 |
$174.32 |
| 81003 |
|
236 |
183 |
$169.61 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$145.96 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
121 |
81 |
$92.69 |
| A7035 |
Headgear used with positive airway pressure device |
15 |
12 |
$60.96 |
| 87088 |
|
40 |
24 |
$59.62 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
16 |
12 |
$40.61 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
12 |
12 |
$14.03 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
75 |
35 |
$7.97 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
43 |
38 |
$4.69 |
| A9270 |
Non-covered item or service |
2,530 |
623 |
$0.00 |